Detalles de la búsqueda
1.
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Respir Res
; 22(1): 127, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906653
2.
Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2.
J Pharmacol Exp Ther
; 362(2): 338-346, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28611093
3.
Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress.
J Pharmacol Exp Ther
; 363(1): 114-125, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28790194
4.
Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Am J Respir Crit Care Med
; 192(7): 785-92, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26132989
5.
Development of Respercise® a Digital Application for Standardizing Home Exercise in COPD Clinical Trials.
Chronic Obstr Pulm Dis
; 8(2): 269-276, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780603
6.
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
J Med Chem
; 59(8): 3991-4006, 2016 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27031670
Resultados
1 -
6
de 6
1
Próxima >
>>